AZN Jun 2024 90.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0100

0.0000

(0.00%)

As of 09:32AM EDT. Market open.

Loading interactive chart…

Zacks
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
The European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for ER-positive, HER2-negative advanced or metastatic breast cancer.
Simply Wall St.
Admiral Group And Two Other UK Exchange Stocks Estimated As Undervalued For Investment Consideration
The United Kingdom's financial markets are currently poised at a critical juncture, with the FTSE 100's movements closely tied to the upcoming release of May's inflation data and decisions from the Bank of England. Amid these market conditions, identifying undervalued stocks can offer investors potential opportunities for growth in a fluctuating economic environment.
Zacks
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
AstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients with locally advanced/metastatic triple-negative breast cancer fails to meet the dual primary endpoints.